Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Daily Grime - City Of London Inv. Group; Rosenblatt Group

ByJeremy Grime
Published 16/09/2019, 09:50
Updated 09/07/2023, 11:32

City Of London Investment Group (LON:CLIG) - FY Results

Share Price 420p

Mkt Cap £111m

Conflict Disclosure: No Holding

  • Results – FUN $5.4bn at 30 June is up 6% over the year while management fee revenues were down6% to £31.9m and PBT down 11% to £11.4m. EPS down 12% to 34.9p and the full year dividend payment amounts to 40.5p of which 13.5p was a special dividend. The average AUM was down 3% over the year while the fee margin declined 5% to 76 bps while costs increased in part due to the new REIT team joining. The outlook is “optimistic” and hopes for a return to profit growth in the current year. It also encourages all shareholders to both “attend the AGM” and “read the rest of this report”.

  • Estimates Results are in line with estimates and for the current year a 3% improvement in pre tax profit is anticipated to £11.7m.

  • Valuation EV/AUM is 2.1%. PER 11.5X, Yield 6.4%. The only share cheaper fund manager on an EV/AUM basis is Premier/Miton at c 2%, while Jupiter trades at 3.3%.

    • Conclusion With Barry Olliff leaving at the end of December combined with a volatile share the shares are cheap. The company has invested in staff and new teams and I suspect the risks of management change may well turn out to be benefits. The shares could do well, or corporate activity may benefit shareholders

    Rosenblatt Group (LON:RBGP) – Acquisition

    Share Price 88p

    Mkt Cap £71m

    Conflict Disclosure: No Holding

  • Acquisition – Rosenblatt is buying a Manchester based corporate finance boutique, Convex Capital Limited for up to £22m, 40% in cash, 60% shares with initial consideration of £13.6m. The company is changing its name to RBG Holdings Plc, as it evolves to become a broad based supplier of professional services. The acquisition is immediately and materially earnings enhancing. Last year Convex delivered £8.7m revenue and £4.3m PBT, which would make the maximum acquisition cost 5.1X PBT and 2.5X last years revenue. Trading is confirmed to be in line with 1 August update. That update confirmed the corporate division was experiencing delays while overall trading was in line.

  • Estimates The acquisition involves potentially the issue of £13.2m shares, which is 18.6% of the market cap, while adding last year’s Convex PBT increases PBT by almost 60%. That maths suggests 50% plus earnings enhancement

  • Valuation PER 11.9X, Yield 5.1%.

    • Conclusion: Rosenblatt has the lumpiest of the lawyer revenues. Adding another unpredictable corporate transaction based business to create earnings enhancement doesn’t necessarily make a good investment. Finncap have done the same with Cavendish. I can’t help but feel there is a reason these corporate finance boutiques don’t float on their own. And to do this at a time when corporate transaction are being delayed according to Rosenblatt’s 1 August statement has a defensive feel. The maths of earnings enhancement is very different to efficient capital allocation. We can expect a de-rating.

    Latest comments

    Install Our App
    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.